These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. Comparison of NMP22 BladderChek test and urine cytology for the detection of recurrent bladder cancer. Kumar A; Kumar R; Gupta NP Jpn J Clin Oncol; 2006 Mar; 36(3):172-5. PubMed ID: 16520358 [TBL] [Abstract][Full Text] [Related]
16. Are cystoscopy and urinary cytology sufficient to identify candidates for subsequent biopsy after bacillus Calmette-Guérin treatment in patients with bladder carcinoma in situ? Haase RN; Harving N Scand J Urol; 2015; 49(4):338-40. PubMed ID: 25660358 [No Abstract] [Full Text] [Related]
17. The value of urine cytology in the diagnosis of recurrent bladder tumors. A preliminary report. reichborn-Kjennerud S; Hoeg K Acta Cytol; 1972; 16(3):269-72. PubMed ID: 4503072 [No Abstract] [Full Text] [Related]
18. [Clinical application of flow cytometry in urology. 3. Correlation between urinary cytology and flow cytometry]. Tachibana M; Nakamura S; Shibayama T; Jitsukawa S; Deguchi N; Baba S; Nakazono M; Hata M; Tazaki H Nihon Hinyokika Gakkai Zasshi; 1986 Nov; 77(11):1864-7. PubMed ID: 3573470 [No Abstract] [Full Text] [Related]
19. Assessing treatment response after induction Bacillus Calmette-Guerin for carcinoma in situ of the urinary bladder: can post-induction random bladder biopsies be avoided? Smith PJ; Lotan Y; Raj GV; Sagalowsky AI; Margulis V Cytopathology; 2014 Apr; 25(2):108-11. PubMed ID: 23551700 [TBL] [Abstract][Full Text] [Related]
20. The role of urinary cytology for detection of bladder cancer. Planz B; Jochims E; Deix T; Caspers HP; Jakse G; Boecking A Eur J Surg Oncol; 2005 Apr; 31(3):304-8. PubMed ID: 15780568 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]